Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study
- PMID: 36266699
- PMCID: PMC9583573
- DOI: 10.1186/s12967-022-03691-2
Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study
Abstract
Background: Although anxiety disorders are one of the most prevalent mental disorders, their underlying biological mechanisms have not yet been fully elucidated. In recent years, genetically determined metabolites (GDMs) have been used to reveal the biological mechanisms of mental disorders. However, this strategy has not been applied to anxiety disorders. Herein, we explored the causality of GDMs on anxiety disorders through Mendelian randomization study, with the overarching goal of unraveling the biological mechanisms.
Methods: A two-sample Mendelian randomization (MR) analysis was implemented to assess the causality of GDMs on anxiety disorders. A genome-wide association study (GWAS) of 486 metabolites was used as the exposure, whereas four different GWAS datasets of anxiety disorders were the outcomes. Notably, all datasets were acquired from publicly available databases. A genetic instrumental variable (IV) was used to explore the causality between the metabolite and anxiety disorders for each metabolite. The MR Steiger filtering method was implemented to examine the causality between metabolites and anxiety disorders. The standard inverse variance weighted (IVW) method was first used for the causality analysis, followed by three additional MR methods (the MR-Egger, weighted median, and MR-PRESSO (pleiotropy residual sum and outlier) methods) for sensitivity analyses in MR analysis. MR-Egger intercept, and Cochran's Q statistical analysis were used to evaluate possible heterogeneity and pleiotropy. Bonferroni correction was used to determine the causative association features (P < 1.03 × 10-4). Furthermore, metabolic pathways analysis was performed using the web-based MetaboAnalyst 5.0 software. All statistical analysis were performed in R software. The STROBE-MR checklist for the reporting of MR studies was used in this study.
Results: In MR analysis, 85 significant causative relationship GDMs were identified. Among them, 11 metabolites were overlapped in the four different datasets of anxiety disorders. Bonferroni correction showing1-linoleoylglycerophosphoethanolamine (ORfixed-effect IVW = 1.04; 95% CI 1.021-1.06; Pfixed-effect IVW = 4.3 × 10-5) was the most reliable causal metabolite. Our results were robust even without a single SNP because of a "leave-one-out" analysis. The MR-Egger intercept test indicated that genetic pleiotropy had no effect on the results (intercept = - 0.0013, SE = 0.0006, P = 0.06). No heterogeneity was detected by Cochran's Q test (MR-Egger. Q = 7.68, P = 0.742; IVW. Q = 12.12, P = 0.436). A directionality test conducted by MR Steiger confirmed our estimation of potential causal direction (P < 0.001). In addition, two significant pathways, the "primary bile acid biosynthesis" pathway (P = 0.008) and the "valine, leucine, and isoleucine biosynthesis" pathway (P = 0.03), were identified through metabolic pathway analysis.
Conclusion: This study provides new insights into the causal effects of GDMs on anxiety disorders by integrating genomics and metabolomics. The metabolites that drive anxiety disorders may be suited to serve as biomarkers and also will help to unravel the biological mechanisms of anxiety disorders.
Keywords: 1-linoleoylglycerophosphoethanolamine; Anxiety disorders; Genetically determined metabolites; Mendelian randomization; Serum metabolite.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.
Figures
Similar articles
-
Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Apr 26;15:1307944. doi: 10.3389/fendo.2024.1307944. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38737546 Free PMC article.
-
Causal effects of genetically determined metabolites and metabolite ratios on esophageal diseases: a two-sample Mendelian randomization study.BMC Gastroenterol. 2024 Sep 14;24(1):310. doi: 10.1186/s12876-024-03411-8. BMC Gastroenterol. 2024. PMID: 39271994 Free PMC article.
-
Estimating the causal effect of frailty index on vestibular disorders: A two-sample Mendelian randomization.Front Neurosci. 2022 Aug 24;16:990682. doi: 10.3389/fnins.2022.990682. eCollection 2022. Front Neurosci. 2022. PMID: 36090295 Free PMC article.
-
Exploring the potential causal relationship between gut microbiota and heart failure: A two-sample mendelian randomization study combined with the geo database.Curr Probl Cardiol. 2024 Feb;49(2):102235. doi: 10.1016/j.cpcardiol.2023.102235. Epub 2023 Nov 30. Curr Probl Cardiol. 2024. PMID: 38040216 Review.
-
Does Walking Have an Association with Osteoarthritis? A Two-Sample Mendelian Randomization Analysis.Clin Interv Aging. 2024 Jan 31;19:153-161. doi: 10.2147/CIA.S442259. eCollection 2024. Clin Interv Aging. 2024. PMID: 38312845 Free PMC article. Review.
Cited by
-
Genetically predicted 486 blood metabolites in relation to risk of esophageal cancer: a Mendelian randomization study.Front Mol Biosci. 2024 Oct 2;11:1391419. doi: 10.3389/fmolb.2024.1391419. eCollection 2024. Front Mol Biosci. 2024. PMID: 39417005 Free PMC article.
-
Association between gut microbiota and diabetic nephropathy: a two-sample mendelian randomization study.BMC Endocr Disord. 2024 Oct 11;24(1):214. doi: 10.1186/s12902-024-01746-7. BMC Endocr Disord. 2024. PMID: 39390505 Free PMC article.
-
Investigating the relationship between blood metabolites and diabetic retinopathy using two-sample mendelian randomization and in vivo validation.Sci Rep. 2024 Oct 3;14(1):22947. doi: 10.1038/s41598-024-73337-4. Sci Rep. 2024. PMID: 39362968 Free PMC article.
-
Chronic noise exposure induces Alzheimer's disease-like neuropathology and cognitive impairment via ferroptosis in rat hippocampus.Environ Health Prev Med. 2024;29:50. doi: 10.1265/ehpm.24-00126. Environ Health Prev Med. 2024. PMID: 39343514 Free PMC article.
-
Lipid metabolites and sarcopenia-related traits: a Mendelian randomization study.Diabetol Metab Syndr. 2024 Sep 16;16(1):231. doi: 10.1186/s13098-024-01465-y. Diabetol Metab Syndr. 2024. PMID: 39285470 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources